Let's not get too excited on the reports of Cantor and the likes. We have heard it all before and nothing has materialised. The reality is that MSB is at $1.17 which many may consider is undervalued in light of the progress made. There are milestones to be reached, revenues to be realised before the price can take off. So just be patient and await positive developments promised in 2019.
$MESO Mesoblast Ltd Receives a Buy from Cantor Fitzgerald with a $23 price target., page-13
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.23%) |
Mkt cap ! $1.250B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.04 | $14.57M | 13.49M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 21024 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 241 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |